Advanced Ann Arbor staging on preliminary presentation for lymphomas
| Disease class∗ . | Characteristics . | OR . | 95% CI . | P value . |
|---|---|---|---|---|
| Hodgkin | Total | 1.06 | 1.04-1.07 | <.001 |
| SES | 1.04 | 1.02-1.05 | <.001 | |
| Minority language status | 1.06 | 1.04-1.08 | <.001 | |
| Household composition | 1.01 | 0.99-1.02 | .514 | |
| Housing and transportation | 1.05 | 1.04-1.07 | <.001 | |
| Non-Hodgkin, extranodal | Total | 1.03 | 1.02-1.04 | <.001 |
| SES | 1.03 | 1.02-1.04 | <.001 | |
| Minority language status | 0.98 | 0.97-0.99 | <.001 | |
| Household composition | 1.03 | 1.01-1.04 | <.001 | |
| Housing and transportation | 1.02 | 1.01-1.03 | .001 | |
| Non-Hodgkin, nodal | Total | 1.00 | 0.99-1.00 | .292 |
| SES | 0.98 | 0.98-0.99 | <.001 | |
| Minority language Status | 1.03 | 1.02-1.04 | <.001 | |
| Household composition | 0.96 | 0.96-0.97 | <.001 | |
| Housing and transportation | 1.01 | 1.00-1.01 | .019 |
| Disease class∗ . | Characteristics . | OR . | 95% CI . | P value . |
|---|---|---|---|---|
| Hodgkin | Total | 1.06 | 1.04-1.07 | <.001 |
| SES | 1.04 | 1.02-1.05 | <.001 | |
| Minority language status | 1.06 | 1.04-1.08 | <.001 | |
| Household composition | 1.01 | 0.99-1.02 | .514 | |
| Housing and transportation | 1.05 | 1.04-1.07 | <.001 | |
| Non-Hodgkin, extranodal | Total | 1.03 | 1.02-1.04 | <.001 |
| SES | 1.03 | 1.02-1.04 | <.001 | |
| Minority language status | 0.98 | 0.97-0.99 | <.001 | |
| Household composition | 1.03 | 1.01-1.04 | <.001 | |
| Housing and transportation | 1.02 | 1.01-1.03 | .001 | |
| Non-Hodgkin, nodal | Total | 1.00 | 0.99-1.00 | .292 |
| SES | 0.98 | 0.98-0.99 | <.001 | |
| Minority language Status | 1.03 | 1.02-1.04 | <.001 | |
| Household composition | 0.96 | 0.96-0.97 | <.001 | |
| Housing and transportation | 1.01 | 1.00-1.01 | .019 |
Univariate logistic regressions across SVI quintiles based on advanced staging on first presentation occurrence for increasing total SVI score and subcomponent SVI theme subscores per lymphoma category. Reference group for outcome, combining “early” staging/“stage I or II,” ; this was compared with the group comprised of “advanced”/“stage III-IV.” Reference group for ordinal variates (total SVI and its themes) were the lowest relative SVI quintile and ordinally increasing factors of sequentially more vulnerable quintiles as comparators.
By InteICD for Oncology, third edition (ICD-O-3).